*Disclaimer

RACE ONCOLOGY LTD (ASX: RAC)

🔗 📄 📈

RAC: Race Receives Additional $1.66m R&D Tax Refund for FY 2022

RACE ONCOLOGY LTD

2023-07-13 10:58:00

RAC: Race executes agreement with Ardena for GMP manufacturing

RACE ONCOLOGY LTD

2023-07-12 09:10:00

RAC: Race global agreement with City of Hope to access FTO IP

RACE ONCOLOGY LTD

2023-07-10 09:10:00

RAC: Race releases complete cardio-protection data & video

RACE ONCOLOGY LTD

2023-04-14 09:06:00

RAC: Race releases cardioprotection market potential data

RACE ONCOLOGY LTD

2023-04-04 09:20:00

RAC: Race Receives $1.48m R&D Tax Refund for Financial Year 2022

RACE ONCOLOGY LTD

2023-03-27 11:25:00

RAC: Race Leadership Changes

RACE ONCOLOGY LTD

2023-03-24 08:53:00

RAC: Race Executes Contracts to Commence Breast Cancer Trial

RACE ONCOLOGY LTD

2023-03-13 09:11:00

RAC: New Collaboration to Understand Zantrene Cardioprotection

RACE ONCOLOGY LTD

2023-03-02 12:33:00

RAC: Race Receives Cardioprotection Ethics Trial Approval

RACE ONCOLOGY LTD

2023-02-01 09:26:00